lanreotide prolonged-release formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for lanreotide prolonged-release formulation, covering 2019-04-25 to 2019-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly [Phase 1, Phase 2]